Roles of endogenous opioid peptides in modulation of nocifensive response to formalin

Journal of Pharmacology and Experimental Therapeutics

Volumn 300, Issue 2, 2002, Pages 647-654

  Wu, Hsiang En ^a   Hung, Kuei Chun ^a   Mizoguchi, Hirokazu ^a   Nagase, Hiroshi ^b   Tseng, Leon F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 BENZYLIDENE NALTREXAMINE; BINALTORPHIMINE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; EPSILON OPIATE RECEPTOR ANTAGONIST; FORMALDEHYDE; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALTRIBEN; NALTRINDOLE; OPIATE ANTAGONIST; OPIATE PEPTIDE; SIGMA OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BLOCKING; DYNORPHINS; ENDORPHINS; ENKEPHALINS; FORMALDEHYDE; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED ICR; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; RECEPTORS, OPIOID; SOMATOSTATIN; SPINAL CORD;

EID: 0036154064     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.300.2.647     Document Type: Article

References (40)

1. A dose-ratio comparison of mu and kappa agonists in formalin and thermal pain
2. Improving the efficiency of the formalin test
3. Subcutaneous formalin induces a segmental release of met-enkephalin-like material from the rat spinal cord
4. Delta antagonist, Naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine
5. Assessing transient and persistent pain in animals
6. The formalin test: A quantitative study of the analgesic effects for morphine, meperidine, and brain stem stimulation in rats and cats
7. Central changes of beta-endorphin-like immunoreactivity during rat tonic pain differ from those of purified beta-endorphin
8. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse
9. Effects of lesion and stimulation of rats hypothalamic arcuate nucleus on the pain system
10. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of fos-like immunoreactivity in the spinal cord of the rat
11. β-endorphin-(1-27) is an antagonist of β-endorphin analgesia
12. Radioimmunoassay of beta-endorphin basal and stimulated level in extracted rat plasma
13. Formalin test in mice, a useful technique to evaluation mild analgesia
14. The formalin test in mice: Dissociation between inflammation and non-inflammatory pain
15. Intrathecal morphine in mice: A new technique
16. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: Stimulus specificity, behavioral parameters and opioid receptor binding
17. Involvement of the dorsolateral funiculi in the spinal release of met-enkephalin-like material triggered by heterosegmental noxious mechanical stimuli
18. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent
19. Opioid systems in the response to inflammatory pain: Sustained blockade suggests role of κ- but not μ-opioid receptors in the modulation of nociception, behavior and pathology
20. Antisense oligodeoxynucleotide to a δ-opioid receptor blocks the antinociception induced by cold water swimming
21. Activation of G-protein in the mouse pons/medulla by β-endorphin is mediated by the stimulation of μ- and putative ε-receptors
22. Biochemical and pharmacological characterization of multiple beta-endorphinergic antinociceptive systems in the rat periaqueductal gray
23. Tonic pain perception in the mouse: Differential modulation by three receptor-selective opioid agonists
24. Methodological refinements to the mouse paw formalin test
25. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: Demonstration of an opioid kappa and delta inhibitory tone
26. Central beta-endorphin system involvement in the reaction to acute tonic pain
27. Formalin-evoked activity in identified primary afferent fibers: Systemic lidocaine suppresses phase-2 activity
28. Modified formalin test: Characteristic biphasic pain response
29. Opioid receptor selectivity of β-endorphin in vitro and in vivo: Mu, delta and epsilon receptors
30. Characterization of dynorphin A-converting enzymes in human spinal cord
31. Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice
32. Evidence that norbinaltorphimine can function as an antagonist at multiple opioid receptor subtypes
33. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered β-endorphin and morphine or DPDPE in mice
34. 5-enkephalin- and U50,488H-induced analgesia in mice
35. The formalin test: An evaluation of the method
36. Different mechanisms mediate β-endorphin- and morphine-induced inhibition of the tail-flick response in rats
37. Evidence for ε-opioid receptor-mediated β-endorphin-induced analgesia
38. Immunocytochemical localization of pro-opiomelanocortin-derived peptides in adults rat spinal cord
39. Antisera against endogenous opioids increase the nocifensive response to formalin: Demonstration of inhibitory β-endorphinergic control
40. Nociceptive stimulus induces release of endogenous β-endorphin in the rat brain